Philips buys China's No 2 in patient monitoring for Asian expansion:
This article was originally published in Clinica
In a move to broaden its presence in the Chinese healthcare market, Philips has acquired China's second largest patient monitoring company, Shenzhen Goldway Industrial. Goldway's range of FDA-cleared and CE-marked patient monitors helped the company grow its sales by 30% in 2007. The 290-strong company has a distribution network that serves mid- and large-sized hospitals throughout China, according to Philips. On completion of the transaction, which is expected in the second quarter of 2008, Goldway will become part of Philips Healthcare's patient monitoring division.
You may also be interested in...
Towa’s US-based Breckenridge is aiming for exclusivity with its generic version of Amgen’s Kyprolis – developed with partner Natco Pharma – after obtaining one of the first approvals for several strengths of the treatment for relapsed or refractory multiple myeloma.
As Nestlé continues to expand its presence in the VMS market it will not take a brand popular in one country and “force” that name on consumers in a different part of the world, says CEO Mark Schneider.
Lupin has claimed a first with a UK approval for a rival to Fostair. The Indian company has told Generics Bulletin that it is planning to roll out the Luforbec branded generic later this year.